Lilly's breast cancer drug succeeds in study, shares rise 11%

Eli Lilly and Co said on Tuesday its treatment, Verzenio, met the trial goal of reducing the risk of early-stage breast cancer returning, sending the company's shares up 11%. [Source]

Origin: reuters.com

Category: healthNews

Topics: shares, cancer, breast, company's, sending, returning, early-stage, reducing, trial, Verzenio, treatment, Lilly, study, succeeds, Lilly's

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/zCgKFzb5r-E/lillys-breast-cancer-drug-succeeds-in-study-shares-rise-11-idUSKBN23N1XU